Loading
NB
Nexvet Biopharma plc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by GEARING DAVID, was filed 07 Mar 2016.
Nexvet Biopharma plc: what insiders have been doing
Every trade that managers of Nexvet Biopharma plc disclose to SEC (Form 4) is tracked on this page. Nexvet Biopharma plc has had no insider filing for more than a year; the last one goes back to 2 August 2017.
Over the whole record (from 2016), the tally stands at 31 purchases and 1 sale.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
130
Thresholds
n/a
Buy Volume
€1M
31 ops. · all time
Sell Volume
€397
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2015FY ended June 2015 · cache
Income statement
RevenueUS$22.3k
Net income-US$17.3M-77460.0% margin
Last declaration on 2 August 2017
Declarations130 total
833,845 shares@ US$6.7210.2% of flowOrdinary SharesSEC:0001182489-17-000447:0
899,268 shares@ US$6.7211.0% of flowOrdinary SharesSEC:0001182489-17-000447:1
915,583 shares@ US$6.7211.2% of flowOrdinary SharesSEC:0001182489-17-000447:2
122,006 shares@ US$6.721.5% of flowOrdinary SharesSEC:0001182489-17-000447:3
249,462 shares@ US$6.723.1% of flowOrdinary SharesSEC:0001182489-17-000447:4
209,577 shares@ US$6.722.6% of flowOrdinary SharesSEC:0001182489-17-000447:5
2,067,651 shares@ US$6.7225.3% of flowOrdinary SharesSEC:0001182489-17-000447:6
2,648,696 shares@ US$6.7232.4% of flowOrdinary SharesSEC:0001182489-17-000447:7
833,845 shares@ US$6.7210.5% of flowOrdinary SharesSEC:0001182489-17-000449:0
899,268 shares@ US$6.7211.3% of flowOrdinary SharesSEC:0001182489-17-000449:1
915,583 shares@ US$6.7211.5% of flowOrdinary SharesSEC:0001182489-17-000449:2
122,006 shares@ US$6.721.5% of flowOrdinary SharesSEC:0001182489-17-000449:3
249,462 shares@ US$6.723.1% of flowOrdinary SharesSEC:0001182489-17-000449:4
209,577 shares@ US$6.722.6% of flowOrdinary SharesSEC:0001182489-17-000449:5
2,067,651 shares@ US$6.7226.0% of flowOrdinary SharesSEC:0001182489-17-000449:6
2,648,696 shares@ US$6.7233.3% of flowOrdinary SharesSEC:0001182489-17-000449:7
16,020 shares@ US$6.7286.6% of flowOrdinary SharesSEC:0001572426-17-000024:0
1,500 shares@ US$6.728.1% of flowOrdinary SharesSEC:0001572426-17-000024:1
109,810 shares@ US$6.7230.9% of flowOrdinary SharesSEC:0001572426-17-000026:0
243,587 shares@ US$6.7268.6% of flowOrdinary SharesSEC:0001572426-17-000026:1
10,800 shares@ US$6.7263.0% of flowOrdinary SharesSEC:0001572426-17-000036:0
6,195 shares@ US$6.7236.2% of flowOrdinary SharesSEC:0001572426-17-000036:1
67,750 shares@ US$6.7260.8% of flowOrdinary SharesSEC:0001572426-17-000032:0
21,239 shares@ US$6.7219.1% of flowOrdinary SharesSEC:0001572426-17-000032:1
18,724 shares@ US$6.7216.8% of flowOrdinary SharesSEC:0001572426-17-000032:2
25 of 130 declarations
About Nexvet Biopharma plc
Nexvet Biopharma plc is a biopharmaceutical company focused on developing innovative treatments for companion animals. It is listed on NASDAQ under the symbol NVET.
